 |
|
Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
Pil Soo Sung, Eun Byul Lee, Dong Jun Park, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clin Mol Hepatol. 2018;24(3):302-310. Published online 2018 Mar 12 DOI: https://doi.org/10.3350/cmh.2017.0074
|
|
Citations to this article as recorded by
 Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication
Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu
Clinical and Molecular Hepatology.2024; 30(3): 326. CrossRef Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?
Carlo Smirne, Maria Grazia Crobu, Irene Landi, Nicole Vercellino, Daria Apostolo, David James Pinato, Federica Vincenzi, Rosalba Minisini, Stelvio Tonello, Davide D’Onghia, Antonio Ottobrelli, Silvia Martini, Christian Bracco, Luigi Maria Fenoglio, Mauro
Viruses.2024; 16(12): 1899. CrossRef Transcriptional responses define dysregulated immune activation in Hepatitis C (HCV)-naïve recipients of HCV-infected donor kidneys
Julie M. Steinbrink, Cameron Miller, Rachel A. Myers, Scott Sanoff, Anna Mazur, Thomas W. Burke, Jennifer Byrns, Annette M. Jackson, Xunrong Luo, Micah T. McClain, Jason T. Blackard
PLOS ONE.2023; 18(1): e0280602. CrossRef DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people
Samaa T. Gobran, Amélie Pagliuzza, Omar Khedr, Augustine Fert, Nicolas Chomont, Julie Bruneau, Marina B. Klein, Petronela Ancuta, Naglaa H. Shoukry, Viviana Simon
Journal of Virology.2023;[Epub] CrossRef Soluble Immune Checkpoint Protein CD27 Is a Novel Prognostic Biomarker of Hepatocellular Carcinoma Development in Hepatitis C Virus–Sustained Virological Response Patients
Minh Phuong Dong, Le Thi Thanh Thuy, Dinh Viet Hoang, Hoang Hai, Truong Huu Hoang, Misako Sato-Matsubara, Vu Ngoc Hieu, Atsuko Daikoku, Ngo Vinh Hanh, Hayato Urushima, Ninh Quoc Dat, Sawako Uchida-Kobayashi, Masaru Enomoto, Naoko Ohtani, Akihiro Tamori, N
The American Journal of Pathology.2022; 192(10): 1379. CrossRef Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection
Pil Soo Sung, Eui-Cheol Shin
Journal of Clinical Medicine.2021; 10(2): 221. CrossRef Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
Xinhe Zhang, Lin Guan, Haoyu Tian, Zilu Zeng, Jiayu Chen, Die Huang, Ji Sun, Jiaqi Guo, Huipeng Cui, Yiling Li
Frontiers in Oncology.2021;[Epub] CrossRef HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
Óscar Brochado-Kith, Isidoro Martínez, Juan Berenguer, Juan González-García, Sergio Salgüero, Daniel Sepúlveda-Crespo, Cristina Díez, Víctor Hontañón, Luis Ibañez-Samaniego, Leire Pérez-Latorre, Amanda Fernández-Rodríguez, María Ángeles Jiménez-Sousa, Sal
Frontiers in Immunology.2021;[Epub] CrossRef A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection
Samaa T. Gobran, Petronela Ancuta, Naglaa H. Shoukry
Frontiers in Immunology.2021;[Epub] CrossRef Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms
Bing Sun, Linda Abadjian, Alexander Monto, Heather Freasier, Lynn Pulliam
The Journal of Infectious Diseases.2020; 222(3): 396. CrossRef Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals
Pil Soo Sung, Eui-Cheol Shin
International Journal of Molecular Sciences.2020; 21(7): 2583. CrossRef Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment Srikanta Dash, Yucel Aydin, Kyle E Widmer, Leela Nayak
Journal of Hepatocellular Carcinoma.2020; Volume 7: 45. CrossRef EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
Dong Jun Park, Pil Soo Sung, Jung-Hee Kim, Gil Won Lee, Jeong Won Jang, Eun Sun Jung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Journal for ImmunoTherapy of Cancer.2020; 8(1): e000301. CrossRef Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics
Luca Rinaldi, Riccardo Nevola, Gianluigi Franci, Alessandro Perrella, Giusy Corvino, Aldo Marrone, Massimiliano Berretta, Maria Vittoria Morone, Marilena Galdiero, Mauro Giordano, Luigi Elio Adinolfi, Ferdinando Carlo Sasso
Cancers.2020; 12(6): 1351. CrossRef microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and De Novo Lipogenesis
Eun Byul Lee, Pil Soo Sung, Jung-Hee Kim, Dong Jun Park, Wonhee Hur, Seung Kew Yoon
Viruses.2020; 12(7): 696. CrossRef Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?
Silvia Martina Ferrari, Poupak Fallahi, Ilaria Ruffilli, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Armando Patrizio, Valeria Mazzi, Michele Colaci, Dilia Giuggioli, Clodoveo Ferri, Alessandro Antonelli
Journal of Immunology Research.2019; 2019: 1. CrossRef APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
Tatsuo Kanda, George K. K. Lau, Lai Wei, Mitsuhiko Moriyama, Ming-Lung Yu, Wang-Long Chuang, Alaaeldin Ibrahim, Cosmas Rinaldi Adithya Lesmana, Jose Sollano, Manoj Kumar, Ankur Jindal, Barjesh Chander Sharma, Saeed S. Hamid, A. Kadir Dokmeci, Mamun-Al-Ma
Hepatology International.2019; 13(6): 649. CrossRef Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
Reina Sasaki, Tatsuo Kanda, Naoya Kato, Osamu Yokosuka, Mitsuhiko Moriyama
World Journal of Hepatology.2018; 10(12): 898. CrossRef Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications
Pil Soo Sung, Jeong Won Jang
International Journal of Molecular Sciences.2018; 19(11): 3648. CrossRef
|